Neonatal jaundice

Pat McKiernan1

  • 1Liver Unit, Birmingham Children's Hospital, West Midlands, United Kingdom. Pat.Mckiernan@bch.nhs.uk

Insights

Prolonged neonatal jaundice requires investigation for liver disease. Prompt diagnosis and management, including vitamin supplementation, improve outcomes for infants with neonatal hepatitis syndrome.

Area of Science:

  • Pediatrics
  • Hepatology
  • Neonatology

Background:

  • Neonatal jaundice exceeding two weeks warrants thorough investigation.
  • Pale stools and dark or yellow urine indicate potential liver disease requiring urgent medical attention.
  • Neonatal hepatitis syndrome encompasses diverse etiologies necessitating a systematic diagnostic approach.

Purpose of the Study:

  • To outline a structured approach for investigating neonatal jaundice and hepatitis.
  • To emphasize the importance of timely diagnosis and intervention for conditions like biliary atresia.
  • To highlight optimal management strategies and prognostic factors for neonatal cholestasis.

Main Methods:

  • Review of diagnostic criteria and investigations for neonatal liver disease.
  • Emphasis on the critical timeframe for diagnosing and managing biliary atresia.
  • Guidelines for nutritional and supportive care, including vitamin supplementation.

Main Results:

  • A structured investigation can efficiently diagnose or exclude biliary atresia within one week.
  • Early intervention in biliary atresia is crucial to prevent surgical delays.
  • Infants with idiopathic neonatal hepatitis and multifactorial cholestasis show excellent prognoses with appropriate care.

Conclusions:

  • Prompt investigation of prolonged neonatal jaundice is essential for identifying liver disease.
  • Timely diagnosis and management, particularly for biliary atresia, significantly impact infant outcomes.
  • Vigorous supportive care, including fat-soluble vitamin supplementation, is vital for infants with neonatal hepatitis syndrome.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...